Temporal effect of imatinib adherence on time to remission in chronic myeloid leukemia patients.

Clark, Samantha E; Marcum, Zachary A; Radich, Jerry; Etzioni, Ruth; Basu, Anirban

Clark, Samantha E; Marcum, Zachary A; Radich, Jerry; Etzioni, Ruth; Basu, Anirban.

Afiliación

Clark SE; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA.
Marcum ZA; Aetion Inc., Boston, MA, USA.
Radich J; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, WA, USA.
Etzioni R; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, WA, USA.
Basu A; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA.

J Oncol Pharm Pract ; : 10781552231212207, 2023 Nov 13.

Article en En | MEDLINE | ID: mdl-37960888

Palabras clave

Adherence; chronic myeloid leukemia; dose response; imatinib; longitudinal; survival analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google